Oculogenex

Business Services · California, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

2250 W Whittier Blvd Ste 300, La Habra, ...

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Oculogenex

Oculogenex is a biotechnology company focused on developing innovative gene therapies to improve vision for patients suffering from macular degeneration and other degenerative retinal diseases. Founded by an ophthalmologist, the company aims to provide effective treatment options for patients who currently have limited choices. Their investigational gene therapy seeks to halt the degeneration of central vision and enhance the quality of life for affected individuals. Oculogenex has gained recognition in the biotech community, participating in competitions and receiving grants to further their research and development efforts.Explore more
Oculogenex's Social MediaPopular SearchesOculogenexOculogenex IncSIC Code 87,873NAICS Code 54,541Show more

Oculogenex Org Chart

PhoneEmail
RR
United States flag for contact location.

Chief Operating Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Oculogenex your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Oculogenex

Compare insights from companies similar to Oculogenex, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Oculogenex

<$5M
11-50
Private
-
2020
RR
Ram RamkumarChief Operating Officer
<$5M
11-50
Private
$6.1M
2012
N/A
<$5M
1-10
Private
-
2005
JC
Jason CharishDirector of Translational Medicine
<$5M
11-50
Private
-
2003
AO
Ashley OldfieldAssociate Scientist
<$5M
1-10
Private
-
2012
<$5M
1-10
Private
-
2017
N/A
11-50
Public
$33M
2009
RC
Ryan ConferPresident, CEO & Chief Financial Officer
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Oculogenex is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Oculogenex is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Oculogenex.

Oculogenex Tech Stack

A closer look at the technologies used by Oculogenex

Oculogenex News & Media

  • Forge Biologics and Oculogenex Announce AAV Contract Development and Manufacturing Partnership

    LA HABRA, Calif. & COLUMBUS, Ohio--(BUSINESS WIRE)--Oculogenex, a biotech company developing a novel adeno-associated viral (AAV) gene therapy treatment to stop the degeneration of central vision in patients, and Forge Biologics, a gene therapy-focused contract development and manufacturing organization, today announced a manufacturing partnership to help support the advancement of Oculogenex’s gene therapy program for dry age-related macular degeneration (AMD) toward clinical trials. Forge wil
Read more news

Top Business Services Companies

Frequently Asked Questions Regarding Oculogenex

What is Oculogenex's official website?
Oculogenex's official website is www.oculogenex.com
What is Oculogenex's Revenue?
Oculogenex's revenue is <$5 Million
What is Oculogenex's SIC code?
Oculogenex's SIC: 87,873
What is Oculogenex's NAICS code?
Oculogenex's NAICS: 54,541
How many employees does Oculogenex have?
Oculogenex has 11-50 employees
What industry does Oculogenex belong to?
Oculogenex is in the industry of: Business Services, Research & Development
What is Oculogenex competition?
Oculogenex top competitors include: jCyte, DefiniGEN, Genprex, Chameleon Biosciences
What technology does Oculogenex use?
Some of the popular technologies that Oculogenex uses are: Microsoft 365, BlueHost, Microsoft Exchange Online
What does Oculogenex do?

Oculogenex is a biotechnology company focused on developing innovative gene therapies to improve vision for patients suffering from macular degeneration and other degenerative retinal diseases. Founded by an ophthalmologist, the company aims to provide effective treatment options for patients who currently have limited choices. Their investigationa... l gene therapy seeks to halt the degeneration of central vision and enhance the quality of life for affected individuals. Oculogenex has gained recognition in the biotech community, participating in competitions and receiving grants to further their research and development efforts.Read More

What are Oculogenex social media links?
Oculogenex Linkedin page
Is Oculogenex a public company?
Oculogenex is private company therefore does not currently have an official ticker symbol
See more information about Oculogenex

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.